SEARCH RESULT

Total Matching Records found : 190

Scientifically validated Rs 5 anti-diabetes herbal drug launched by CSIR -Neha Shukla

-The Times of India LUCKNOW: A scientifically validated anti-diabetes herbal drug, named 'BGR-34', was launched by a Council of Scientific and Industrial Research (CSIR) lab in Lucknow on Sunday. A combination of natural extracts from plants, the drug is based on Ayurveda and has no side effects. The drug is for management of type-II diabetes mellitus. The drug has been jointly developed by two CSIR laboratories, National Botanical Research Institute (NBRI) and...

More »

Indians face risk from unproven drugs: Lancet -Rupali Mukherjee

-The Times of India MUMBAI: Certain medicines are being aggressively marketed in India despite inadequate evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...

More »

Rotavirus vaccine makes a case for openness on clinical data -PT Jyothi Datta

-The Hindu Business Line Transparency required on data concerning clinical trials and procurement of drugs Earlier this year, rotavirus vaccine 116E was launched with much fanfare. The celebration of this vaccine that would protect infants against rotavirus gastroenteritis was on two counts. It was developed locally and its price was pegged at $1, less than competing rotavirus vaccines that sell in the country. But the rollout of this indigenous vaccine as part of...

More »

Politics of Immunisation

-Economic and Political Weekly The health ministry's move on HPV vaccine feasibility is ill-advised. The union health ministry has asked the National Technical Advisory Group on Immunisation (NTAGI) to examine the feasibility of introducing the Human Papillomavirus (HPV) vaccine in the country’s universal immunisation programme. The NTAGI has been given three months for this task. The HPV vaccine, which is supposed to protect against cervical cancer in girls and women, is generally...

More »

Medicines in India, for India -Pavan Srinath

-The Hindu Tropical diseases have often been neglected by pharmaceuticals because the size of the drug market is smaller, people have lower incomes and companies are uncertain about IPR January marked an important breakthrough in the fight against tropical diseases. Researchers and the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Delhi found a drug candidate that prevented TB and malaria pathogens from infecting human blood cells. It is not just that...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close